Residual inflammatory risk in coronary heart disease: incidence of elevated high-sensitive CRP in a real-world cohort

BACKGROUND: Inflammation drives atherosclerosis and its complications. Anti-inflammatory therapy with interleukin 1 beta (IL-1β) antibody reduces cardiovascular events in patients with elevated high-sensitive C-reactive protein (hsCRP). This study aims to identify the share of patients with coronary...

Descripción completa

Detalles Bibliográficos
Autores principales: Peikert, Alexander, Kaier, Klaus, Merz, Julian, Manhart, Lucas, Schäfer, Ibrahim, Hilgendorf, Ingo, Hehn, Philipp, Wolf, Dennis, Willecke, Florian, Sheng, Xia, Clemens, Andreas, Zehender, Manfred, von zur Mühlen, Constantin, Bode, Christoph, Zirlik, Andreas, Stachon, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042185/
https://www.ncbi.nlm.nih.gov/pubmed/31325043
http://dx.doi.org/10.1007/s00392-019-01511-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042185/
https://www.ncbi.nlm.nih.gov/pubmed/31325043
http://dx.doi.org/10.1007/s00392-019-01511-0

Ejemplares similares